ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -13.00 | -10.00 | -19.00 | -21.00 | -31.00 | -66.00 | -121.00 | -210.00 | -217.00 | -167.00 | -151.00 | -136.00 | -125.00 | -114.00 | 16.00 | |
| Operating Cash (Net) | -13.00 | -10.00 | -19.00 | -21.00 | -31.00 | -66.00 | -121.00 | -210.00 | -217.00 | -167.00 | -151.00 | -136.00 | -125.00 | -114.00 | 16.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | -5.00 | -11.00 | -8.00 | -9.00 | -12.00 | -16.00 | 2.00 | -39.00 | |
| Accounts Payable | - - | - - | - - | - - | -1.00 | 1.00 | - - | 2.00 | 4.00 | -5.00 | 4.00 | 1.00 | -1.00 | 5.00 | 4.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 27.00 | -27.00 | - - | -2.00 | -1.00 | 9.00 | 4.00 | 4.00 | -6.00 | -8.00 | 3.00 | 11.00 | -24.00 | 37.00 | 18.00 | |
| Other WC | 26.00 | -26.00 | - - | -1.00 | - - | 7.00 | 4.00 | 11.00 | 1.00 | 4.00 | 11.00 | 25.00 | -2.00 | 27.00 | 81.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | 9.00 | -1.00 | 5.00 | -25.00 | -126.00 | -87.00 | 147.00 | -261.00 | 92.00 | -71.00 | -165.00 | 192.00 | -71.00 | 73.00 | 31.00 | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | -2.00 | -9.00 | - - | -2.00 | -1.00 | -7.00 | -1.00 | - - | -40.00 | |
| Purchases of Investments | -50.00 | -54.00 | -48.00 | -56.00 | -211.00 | -335.00 | -269.00 | -683.00 | -478.00 | -331.00 | -578.00 | -339.00 | -492.00 | -363.00 | -369.00 | |
| Sale/Maturity of Investment | 59.00 | 53.00 | 54.00 | 30.00 | 86.00 | 248.00 | 419.00 | 430.00 | 572.00 | 261.00 | 413.00 | 540.00 | 422.00 | 436.00 | 442.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | -2.00 | -9.00 | - - | -2.00 | -1.00 | -7.00 | -1.00 | - - | -40.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | -2.00 | 8.00 | - - | - - | 164.00 | -200.00 | 69.00 | - - | -32.00 | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | 2.00 | -8.00 | - - | - - | -164.00 | 200.00 | -69.00 | 73.00 | 32.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -1.00 | - - | -13.00 | -98.00 | -111.00 | -203.00 | -14.00 | -533.00 | -31.00 | -306.00 | -371.00 | -80.00 | -18.00 | -8.00 | -25.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | 1.00 | - - | 14.00 | 98.00 | 111.00 | 203.00 | 14.00 | 518.00 | 31.00 | 306.00 | 371.00 | 80.00 | 18.00 | 8.00 | 25.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | - - | - - | - - | - - | - - | - - | 14.00 | - - | - - | 371.00 | 80.00 | 18.00 | 8.00 | 25.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 21.00 | 18.00 | 6.00 | 6.00 | 57.00 | 11.00 | 61.00 | 102.00 | 163.00 | 71.00 | 139.00 | 194.00 | 331.00 | 153.00 | 114.00 | |
| End of Period | 18.00 | 6.00 | 6.00 | 57.00 | 11.00 | 61.00 | 102.00 | 163.00 | 69.00 | 139.00 | 194.00 | 331.00 | 153.00 | 120.00 | 188.00 | |
| Change | -3.00 | -11.00 | - - | 51.00 | -46.00 | 50.00 | 40.00 | 61.00 | -94.00 | 67.00 | 54.00 | 137.00 | -178.00 | -32.00 | 73.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 1.00 | - - | - - | - - | - - | - - | - - | 1.00 | 2.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 5.00 | |
| Stock Based Compensation | 2.00 | 1.00 | 1.00 | 1.00 | 5.00 | 16.00 | 40.00 | 55.00 | 75.00 | - - | 82.00 | 84.00 | 63.00 | 68.00 | 66.00 | |
| Other | - - | - - | - - | - - | 1.00 | - - | -2.00 | - - | - - | 1.00 | -4.00 | 44.00 | - - | -6.00 | 128.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -13.00 | -10.00 | -19.00 | -21.00 | -32.00 | -66.00 | -123.00 | -219.00 | -218.00 | -169.00 | -152.00 | -143.00 | -126.00 | -114.00 | -23.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | 172.00 | -45.00 | 63.00 | 24.00 | 62.00 | 68.00 | -174.00 | 197.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |